| GO:0032991 | protein-containing complex | 35.14% (26/74) | 2.92 | 0.0 | 0.0 |
| GO:0003723 | RNA binding | 27.03% (20/74) | 3.62 | 0.0 | 0.0 |
| GO:1990904 | ribonucleoprotein complex | 20.27% (15/74) | 4.56 | 0.0 | 0.0 |
| GO:0005575 | cellular_component | 62.16% (46/74) | 1.64 | 0.0 | 0.0 |
| GO:0003676 | nucleic acid binding | 35.14% (26/74) | 2.42 | 0.0 | 0.0 |
| GO:0005488 | binding | 59.46% (44/74) | 1.4 | 0.0 | 0.0 |
| GO:0008135 | translation factor activity, RNA binding | 9.46% (7/74) | 5.88 | 0.0 | 0.0 |
| GO:0090079 | translation regulator activity, nucleic acid binding | 9.46% (7/74) | 5.88 | 0.0 | 0.0 |
| GO:0071540 | eukaryotic translation initiation factor 3 complex, eIF3e | 5.41% (4/74) | 9.26 | 0.0 | 0.0 |
| GO:0043614 | multi-eIF complex | 5.41% (4/74) | 9.26 | 0.0 | 0.0 |
| GO:0045182 | translation regulator activity | 9.46% (7/74) | 5.7 | 0.0 | 0.0 |
| GO:0002188 | translation reinitiation | 5.41% (4/74) | 9.08 | 0.0 | 0.0 |
| GO:0043228 | non-membrane-bounded organelle | 16.22% (12/74) | 3.7 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 51.35% (38/74) | 1.48 | 0.0 | 0.0 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 16.22% (12/74) | 3.7 | 0.0 | 0.0 |
| GO:0003743 | translation initiation factor activity | 8.11% (6/74) | 6.31 | 0.0 | 0.0 |
| GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 5.41% (4/74) | 8.76 | 0.0 | 0.0 |
| GO:0043226 | organelle | 33.78% (25/74) | 2.05 | 0.0 | 0.0 |
| GO:0001732 | formation of cytoplasmic translation initiation complex | 5.41% (4/74) | 8.58 | 0.0 | 0.0 |
| GO:0043229 | intracellular organelle | 33.78% (25/74) | 2.05 | 0.0 | 0.0 |
| GO:0110165 | cellular anatomical entity | 48.65% (36/74) | 1.46 | 0.0 | 0.0 |
| GO:0002183 | cytoplasmic translational initiation | 5.41% (4/74) | 8.1 | 0.0 | 0.0 |
| GO:0006413 | translational initiation | 6.76% (5/74) | 6.45 | 0.0 | 0.0 |
| GO:0003674 | molecular_function | 68.92% (51/74) | 0.96 | 0.0 | 0.0 |
| GO:0022618 | protein-RNA complex assembly | 8.11% (6/74) | 5.38 | 0.0 | 0.0 |
| GO:0071826 | protein-RNA complex organization | 8.11% (6/74) | 5.34 | 0.0 | 0.0 |
| GO:0005852 | eukaryotic translation initiation factor 3 complex | 5.41% (4/74) | 7.38 | 0.0 | 0.0 |
| GO:0022613 | ribonucleoprotein complex biogenesis | 6.76% (5/74) | 5.96 | 0.0 | 0.0 |
| GO:0008150 | biological_process | 58.11% (43/74) | 1.06 | 0.0 | 1e-06 |
| GO:0042273 | ribosomal large subunit biogenesis | 5.41% (4/74) | 6.81 | 0.0 | 1e-06 |
| GO:0005634 | nucleus | 20.27% (15/74) | 2.45 | 0.0 | 1e-06 |
| GO:0003729 | mRNA binding | 9.46% (7/74) | 4.07 | 0.0 | 4e-06 |
| GO:0071840 | cellular component organization or biogenesis | 17.57% (13/74) | 2.57 | 0.0 | 4e-06 |
| GO:0016071 | mRNA metabolic process | 9.46% (7/74) | 4.03 | 0.0 | 4e-06 |
| GO:0005730 | nucleolus | 8.11% (6/74) | 4.54 | 0.0 | 4e-06 |
| GO:0034641 | cellular nitrogen compound metabolic process | 22.97% (17/74) | 2.1 | 0.0 | 4e-06 |
| GO:0097159 | organic cyclic compound binding | 37.84% (28/74) | 1.4 | 1e-06 | 7e-06 |
| GO:0044237 | cellular metabolic process | 33.78% (25/74) | 1.53 | 1e-06 | 7e-06 |
| GO:0034655 | nucleobase-containing compound catabolic process | 8.11% (6/74) | 4.33 | 1e-06 | 8e-06 |
| GO:0044270 | cellular nitrogen compound catabolic process | 8.11% (6/74) | 4.21 | 1e-06 | 1.2e-05 |
| GO:0046700 | heterocycle catabolic process | 8.11% (6/74) | 4.21 | 1e-06 | 1.2e-05 |
| GO:0140513 | nuclear protein-containing complex | 12.16% (9/74) | 3.03 | 2e-06 | 2e-05 |
| GO:0019439 | aromatic compound catabolic process | 8.11% (6/74) | 4.04 | 2e-06 | 2.3e-05 |
| GO:1901361 | organic cyclic compound catabolic process | 8.11% (6/74) | 4.01 | 2e-06 | 2.5e-05 |
| GO:0006396 | RNA processing | 10.81% (8/74) | 3.17 | 3e-06 | 3.6e-05 |
| GO:0065003 | protein-containing complex assembly | 8.11% (6/74) | 3.91 | 3e-06 | 3.6e-05 |
| GO:0044085 | cellular component biogenesis | 6.76% (5/74) | 4.44 | 4e-06 | 4.1e-05 |
| GO:0005737 | cytoplasm | 16.22% (12/74) | 2.33 | 4e-06 | 4.4e-05 |
| GO:0005854 | nascent polypeptide-associated complex | 2.7% (2/74) | 9.34 | 4e-06 | 4.5e-05 |
| GO:0043933 | protein-containing complex organization | 9.46% (7/74) | 3.39 | 5e-06 | 5.1e-05 |
| GO:0003924 | GTPase activity | 6.76% (5/74) | 4.28 | 7e-06 | 6.4e-05 |
| GO:0005525 | GTP binding | 6.76% (5/74) | 4.22 | 8e-06 | 7.5e-05 |
| GO:0032561 | guanyl ribonucleotide binding | 6.76% (5/74) | 4.22 | 8e-06 | 7.5e-05 |
| GO:0019001 | guanyl nucleotide binding | 6.76% (5/74) | 4.18 | 9e-06 | 8.5e-05 |
| GO:0016070 | RNA metabolic process | 13.51% (10/74) | 2.48 | 1.2e-05 | 0.000111 |
| GO:0000398 | mRNA splicing, via spliceosome | 5.41% (4/74) | 4.78 | 1.6e-05 | 0.000138 |
| GO:0035101 | FACT complex | 2.7% (2/74) | 8.4 | 1.7e-05 | 0.000146 |
| GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5.41% (4/74) | 4.7 | 1.9e-05 | 0.000164 |
| GO:0000375 | RNA splicing, via transesterification reactions | 5.41% (4/74) | 4.58 | 2.6e-05 | 0.000219 |
| GO:0005198 | structural molecule activity | 6.76% (5/74) | 3.82 | 3e-05 | 0.00025 |
| GO:0022607 | cellular component assembly | 8.11% (6/74) | 3.33 | 3.1e-05 | 0.000255 |
| GO:0005681 | spliceosomal complex | 5.41% (4/74) | 4.43 | 3.9e-05 | 0.000299 |
| GO:0006139 | nucleobase-containing compound metabolic process | 17.57% (13/74) | 1.9 | 3.8e-05 | 0.0003 |
| GO:0005840 | ribosome | 5.41% (4/74) | 4.45 | 3.8e-05 | 0.000301 |
| GO:0001731 | formation of translation preinitiation complex | 2.7% (2/74) | 7.8 | 3.9e-05 | 0.000302 |
| GO:0008380 | RNA splicing | 5.41% (4/74) | 4.35 | 4.8e-05 | 0.000364 |
| GO:0003735 | structural constituent of ribosome | 5.41% (4/74) | 4.22 | 6.9e-05 | 0.00051 |
| GO:0046483 | heterocycle metabolic process | 17.57% (13/74) | 1.8 | 7.7e-05 | 0.000553 |
| GO:0022625 | cytosolic large ribosomal subunit | 4.05% (3/74) | 5.23 | 7.7e-05 | 0.000559 |
| GO:0031420 | alkali metal ion binding | 2.7% (2/74) | 7.19 | 9.1e-05 | 0.000622 |
| GO:0004743 | pyruvate kinase activity | 2.7% (2/74) | 7.19 | 9.1e-05 | 0.000622 |
| GO:0030955 | potassium ion binding | 2.7% (2/74) | 7.19 | 9.1e-05 | 0.000622 |
| GO:0006725 | cellular aromatic compound metabolic process | 17.57% (13/74) | 1.77 | 9.7e-05 | 0.000658 |
| GO:0006412 | translation | 5.41% (4/74) | 4.04 | 0.000111 | 0.000741 |
| GO:0044248 | cellular catabolic process | 8.11% (6/74) | 2.99 | 0.000116 | 0.000766 |
| GO:1901360 | organic cyclic compound metabolic process | 17.57% (13/74) | 1.73 | 0.000129 | 0.000842 |
| GO:0008152 | metabolic process | 33.78% (25/74) | 1.07 | 0.000139 | 0.00088 |
| GO:0015934 | large ribosomal subunit | 4.05% (3/74) | 4.94 | 0.000137 | 0.000883 |
| GO:0006397 | mRNA processing | 5.41% (4/74) | 3.93 | 0.000149 | 0.000935 |
| GO:0045292 | mRNA cis splicing, via spliceosome | 2.7% (2/74) | 6.73 | 0.000172 | 0.000935 |
| GO:0009191 | ribonucleoside diphosphate catabolic process | 4.05% (3/74) | 4.84 | 0.000171 | 0.000939 |
| GO:0009134 | nucleoside diphosphate catabolic process | 4.05% (3/74) | 4.84 | 0.000171 | 0.000939 |
| GO:0019364 | pyridine nucleotide catabolic process | 4.05% (3/74) | 4.82 | 0.000176 | 0.000944 |
| GO:0043043 | peptide biosynthetic process | 5.41% (4/74) | 3.92 | 0.000154 | 0.000953 |
| GO:0043227 | membrane-bounded organelle | 20.27% (15/74) | 1.52 | 0.000182 | 0.000957 |
| GO:0046031 | ADP metabolic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0009181 | purine ribonucleoside diphosphate catabolic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0009179 | purine ribonucleoside diphosphate metabolic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0009137 | purine nucleoside diphosphate catabolic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0046032 | ADP catabolic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0009135 | purine nucleoside diphosphate metabolic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0006096 | glycolytic process | 4.05% (3/74) | 4.84 | 0.00017 | 0.000957 |
| GO:0072526 | pyridine-containing compound catabolic process | 4.05% (3/74) | 4.81 | 0.000181 | 0.000963 |
| GO:0043231 | intracellular membrane-bounded organelle | 20.27% (15/74) | 1.53 | 0.000167 | 0.001023 |
| GO:0009261 | ribonucleotide catabolic process | 4.05% (3/74) | 4.75 | 0.000206 | 0.001061 |
| GO:0009154 | purine ribonucleotide catabolic process | 4.05% (3/74) | 4.75 | 0.000205 | 0.001069 |
| GO:0006195 | purine nucleotide catabolic process | 4.05% (3/74) | 4.71 | 0.000221 | 0.001126 |
| GO:0009185 | ribonucleoside diphosphate metabolic process | 4.05% (3/74) | 4.71 | 0.000223 | 0.001129 |
| GO:0009132 | nucleoside diphosphate metabolic process | 4.05% (3/74) | 4.7 | 0.000227 | 0.001135 |
| GO:0009166 | nucleotide catabolic process | 4.05% (3/74) | 4.69 | 0.00023 | 0.001141 |
| GO:1901292 | nucleoside phosphate catabolic process | 4.05% (3/74) | 4.66 | 0.000244 | 0.001197 |
| GO:1901575 | organic substance catabolic process | 9.46% (7/74) | 2.46 | 0.000297 | 0.001442 |
| GO:0006518 | peptide metabolic process | 5.41% (4/74) | 3.66 | 0.000301 | 0.001448 |
| GO:0072523 | purine-containing compound catabolic process | 4.05% (3/74) | 4.55 | 0.000307 | 0.001463 |
| GO:1901566 | organonitrogen compound biosynthetic process | 8.11% (6/74) | 2.71 | 0.00033 | 0.001556 |
| GO:0006402 | mRNA catabolic process | 4.05% (3/74) | 4.47 | 0.000357 | 0.001652 |
| GO:0046034 | ATP metabolic process | 4.05% (3/74) | 4.48 | 0.000355 | 0.001658 |
| GO:0000287 | magnesium ion binding | 4.05% (3/74) | 4.44 | 0.00038 | 0.001743 |
| GO:0009056 | catabolic process | 9.46% (7/74) | 2.38 | 0.0004 | 0.001818 |
| GO:0045184 | establishment of protein localization | 6.76% (5/74) | 3.01 | 0.000408 | 0.001838 |
| GO:0009205 | purine ribonucleoside triphosphate metabolic process | 4.05% (3/74) | 4.4 | 0.000417 | 0.001858 |
| GO:0009144 | purine nucleoside triphosphate metabolic process | 4.05% (3/74) | 4.38 | 0.000432 | 0.00189 |
| GO:0043604 | amide biosynthetic process | 5.41% (4/74) | 3.52 | 0.00043 | 0.0019 |
| GO:0010468 | regulation of gene expression | 12.16% (9/74) | 1.98 | 0.000456 | 0.001981 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 12.16% (9/74) | 1.97 | 0.000479 | 0.002062 |
| GO:1901136 | carbohydrate derivative catabolic process | 4.05% (3/74) | 4.3 | 0.000501 | 0.002138 |
| GO:0009889 | regulation of biosynthetic process | 12.16% (9/74) | 1.94 | 0.000547 | 0.002294 |
| GO:0031326 | regulation of cellular biosynthetic process | 12.16% (9/74) | 1.94 | 0.000544 | 0.002301 |
| GO:0006401 | RNA catabolic process | 4.05% (3/74) | 4.23 | 0.000583 | 0.002423 |
| GO:0042254 | ribosome biogenesis | 2.7% (2/74) | 5.83 | 0.000596 | 0.002459 |
| GO:0044391 | ribosomal subunit | 4.05% (3/74) | 4.21 | 0.000604 | 0.002469 |
| GO:0031332 | RNAi effector complex | 1.35% (1/74) | 10.67 | 0.000616 | 0.002477 |
| GO:0016442 | RISC complex | 1.35% (1/74) | 10.67 | 0.000616 | 0.002477 |
| GO:0070727 | cellular macromolecule localization | 6.76% (5/74) | 2.85 | 0.000673 | 0.002581 |
| GO:0033036 | macromolecule localization | 6.76% (5/74) | 2.85 | 0.000679 | 0.002584 |
| GO:0009199 | ribonucleoside triphosphate metabolic process | 4.05% (3/74) | 4.18 | 0.000648 | 0.002588 |
| GO:0008104 | protein localization | 6.76% (5/74) | 2.86 | 0.000666 | 0.002595 |
| GO:0016787 | hydrolase activity | 16.22% (12/74) | 1.56 | 0.000671 | 0.002596 |
| GO:0005829 | cytosol | 8.11% (6/74) | 2.51 | 0.000662 | 0.0026 |
| GO:0006090 | pyruvate metabolic process | 4.05% (3/74) | 4.17 | 0.000659 | 0.002611 |
| GO:0009141 | nucleoside triphosphate metabolic process | 4.05% (3/74) | 4.13 | 0.000707 | 0.002671 |
| GO:0090304 | nucleic acid metabolic process | 13.51% (10/74) | 1.76 | 0.000718 | 0.002691 |
| GO:0031491 | nucleosome binding | 2.7% (2/74) | 5.67 | 0.00074 | 0.002753 |
| GO:0016043 | cellular component organization | 10.81% (8/74) | 2.03 | 0.000764 | 0.0028 |
| GO:0046434 | organophosphate catabolic process | 4.05% (3/74) | 4.1 | 0.000759 | 0.002805 |
| GO:0046496 | nicotinamide nucleotide metabolic process | 4.05% (3/74) | 4.08 | 0.000789 | 0.002871 |
| GO:0019362 | pyridine nucleotide metabolic process | 4.05% (3/74) | 4.07 | 0.000798 | 0.002884 |
| GO:0030684 | preribosome | 4.05% (3/74) | 4.05 | 0.00084 | 0.003013 |
| GO:0030687 | preribosome, large subunit precursor | 2.7% (2/74) | 5.53 | 0.000899 | 0.0032 |
| GO:0072524 | pyridine-containing compound metabolic process | 4.05% (3/74) | 4.0 | 0.000914 | 0.003209 |
| GO:0060255 | regulation of macromolecule metabolic process | 12.16% (9/74) | 1.84 | 0.000913 | 0.003227 |
| GO:0031323 | regulation of cellular metabolic process | 12.16% (9/74) | 1.83 | 0.000952 | 0.003319 |
| GO:0006807 | nitrogen compound metabolic process | 25.68% (19/74) | 1.09 | 0.001014 | 0.003511 |
| GO:0005515 | protein binding | 18.92% (14/74) | 1.34 | 0.001086 | 0.003734 |
| GO:0008023 | transcription elongation factor complex | 2.7% (2/74) | 5.38 | 0.0011 | 0.003756 |
| GO:0019222 | regulation of metabolic process | 12.16% (9/74) | 1.78 | 0.001187 | 0.004023 |
| GO:0043603 | amide metabolic process | 5.41% (4/74) | 3.1 | 0.001267 | 0.004267 |
| GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6.76% (5/74) | 2.61 | 0.001399 | 0.00468 |
| GO:0005853 | eukaryotic translation elongation factor 1 complex | 1.35% (1/74) | 9.4 | 0.001477 | 0.004906 |
| GO:0006612 | protein targeting to membrane | 2.7% (2/74) | 5.09 | 0.001628 | 0.005374 |
| GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1.35% (1/74) | 9.18 | 0.001723 | 0.005647 |
| GO:0016462 | pyrophosphatase activity | 6.76% (5/74) | 2.52 | 0.001877 | 0.006113 |
| GO:0016052 | carbohydrate catabolic process | 4.05% (3/74) | 3.63 | 0.001912 | 0.006185 |
| GO:0004455 | ketol-acid reductoisomerase activity | 1.35% (1/74) | 8.99 | 0.001968 | 0.006327 |
| GO:0071013 | catalytic step 2 spliceosome | 2.7% (2/74) | 4.94 | 0.001996 | 0.006374 |
| GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 6.76% (5/74) | 2.49 | 0.002021 | 0.006412 |
| GO:0003682 | chromatin binding | 4.05% (3/74) | 3.59 | 0.002049 | 0.006461 |
| GO:0034470 | ncRNA processing | 5.41% (4/74) | 2.91 | 0.002064 | 0.006467 |
| GO:0016817 | hydrolase activity, acting on acid anhydrides | 6.76% (5/74) | 2.48 | 0.002105 | 0.006555 |
| GO:0044877 | protein-containing complex binding | 5.41% (4/74) | 2.88 | 0.002207 | 0.006827 |
| GO:0009059 | macromolecule biosynthetic process | 6.76% (5/74) | 2.42 | 0.002511 | 0.007721 |
| GO:0002926 | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation | 1.35% (1/74) | 8.46 | 0.002828 | 0.008643 |
| GO:0048523 | negative regulation of cellular process | 5.41% (4/74) | 2.78 | 0.002869 | 0.008659 |
| GO:0009150 | purine ribonucleotide metabolic process | 4.05% (3/74) | 3.42 | 0.002854 | 0.008667 |
| GO:0006091 | generation of precursor metabolites and energy | 4.05% (3/74) | 3.41 | 0.002957 | 0.008872 |
| GO:0051641 | cellular localization | 6.76% (5/74) | 2.35 | 0.003082 | 0.00908 |
| GO:0043874 | acireductone synthase activity | 1.35% (1/74) | 8.34 | 0.003074 | 0.009112 |
| GO:0048519 | negative regulation of biological process | 5.41% (4/74) | 2.75 | 0.003056 | 0.009114 |
| GO:0006364 | rRNA processing | 4.05% (3/74) | 3.38 | 0.003141 | 0.0092 |
| GO:0010629 | negative regulation of gene expression | 4.05% (3/74) | 3.3 | 0.003614 | 0.010522 |
| GO:0090150 | establishment of protein localization to membrane | 2.7% (2/74) | 4.5 | 0.003637 | 0.010528 |
| GO:0090114 | COPII-coated vesicle budding | 1.35% (1/74) | 8.08 | 0.003688 | 0.010613 |
| GO:0016072 | rRNA metabolic process | 4.05% (3/74) | 3.26 | 0.00391 | 0.011188 |
| GO:0050794 | regulation of cellular process | 13.51% (10/74) | 1.42 | 0.003951 | 0.01124 |
| GO:0009259 | ribonucleotide metabolic process | 4.05% (3/74) | 3.22 | 0.004226 | 0.011952 |
| GO:0006082 | organic acid metabolic process | 6.76% (5/74) | 2.21 | 0.004653 | 0.012866 |
| GO:0019752 | carboxylic acid metabolic process | 6.76% (5/74) | 2.21 | 0.004582 | 0.012887 |
| GO:0009057 | macromolecule catabolic process | 5.41% (4/74) | 2.58 | 0.004644 | 0.012915 |
| GO:0043436 | oxoacid metabolic process | 6.76% (5/74) | 2.21 | 0.004637 | 0.012968 |
| GO:0019693 | ribose phosphate metabolic process | 4.05% (3/74) | 3.16 | 0.004732 | 0.013013 |
| GO:0050789 | regulation of biological process | 13.51% (10/74) | 1.35 | 0.005566 | 0.015221 |
| GO:0051082 | unfolded protein binding | 2.7% (2/74) | 4.18 | 0.005598 | 0.015226 |
| GO:0042393 | histone binding | 2.7% (2/74) | 4.17 | 0.005634 | 0.015241 |
| GO:0006163 | purine nucleotide metabolic process | 4.05% (3/74) | 3.05 | 0.005895 | 0.015858 |
| GO:0072657 | protein localization to membrane | 2.7% (2/74) | 4.09 | 0.006291 | 0.016743 |
| GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.35% (1/74) | 7.31 | 0.006261 | 0.016753 |
| GO:0071704 | organic substance metabolic process | 27.03% (20/74) | 0.82 | 0.006616 | 0.017512 |
| GO:0034660 | ncRNA metabolic process | 5.41% (4/74) | 2.43 | 0.006696 | 0.01763 |
| GO:0072546 | EMC complex | 1.35% (1/74) | 7.15 | 0.006995 | 0.018129 |
| GO:0016077 | sno(s)RNA catabolic process | 1.35% (1/74) | 7.03 | 0.007607 | 0.01819 |
| GO:0071039 | nuclear polyadenylation-dependent CUT catabolic process | 1.35% (1/74) | 7.03 | 0.007607 | 0.01819 |
| GO:0071036 | nuclear polyadenylation-dependent snoRNA catabolic process | 1.35% (1/74) | 7.03 | 0.007607 | 0.01819 |
| GO:0016076 | snRNA catabolic process | 1.35% (1/74) | 7.03 | 0.007607 | 0.01819 |
| GO:0071037 | nuclear polyadenylation-dependent snRNA catabolic process | 1.35% (1/74) | 7.03 | 0.007607 | 0.01819 |
| GO:0072521 | purine-containing compound metabolic process | 4.05% (3/74) | 2.96 | 0.006987 | 0.018203 |
| GO:0044249 | cellular biosynthetic process | 9.46% (7/74) | 1.65 | 0.006962 | 0.018235 |
| GO:0071265 | L-methionine biosynthetic process | 1.35% (1/74) | 7.01 | 0.007729 | 0.018393 |
| GO:0006886 | intracellular protein transport | 4.05% (3/74) | 2.92 | 0.007528 | 0.018538 |
| GO:0031327 | negative regulation of cellular biosynthetic process | 4.05% (3/74) | 2.9 | 0.007836 | 0.01856 |
| GO:0006605 | protein targeting | 2.7% (2/74) | 3.95 | 0.00758 | 0.018574 |
| GO:0071040 | nuclear polyadenylation-dependent antisense transcript catabolic process | 1.35% (1/74) | 7.08 | 0.007362 | 0.018593 |
| GO:0071041 | antisense RNA transcript catabolic process | 1.35% (1/74) | 7.08 | 0.007362 | 0.018593 |
| GO:0042868 | antisense RNA metabolic process | 1.35% (1/74) | 7.08 | 0.007362 | 0.018593 |
| GO:0071044 | histone mRNA catabolic process | 1.35% (1/74) | 7.08 | 0.007362 | 0.018593 |
| GO:0044238 | primary metabolic process | 25.68% (19/74) | 0.84 | 0.007514 | 0.018597 |
| GO:0043102 | amino acid salvage | 1.35% (1/74) | 7.06 | 0.007484 | 0.018617 |
| GO:0019509 | L-methionine salvage from methylthioadenosine | 1.35% (1/74) | 7.06 | 0.007484 | 0.018617 |
| GO:0071267 | L-methionine salvage | 1.35% (1/74) | 7.06 | 0.007484 | 0.018617 |
| GO:0009890 | negative regulation of biosynthetic process | 4.05% (3/74) | 2.89 | 0.007928 | 0.018687 |
| GO:0010558 | negative regulation of macromolecule biosynthetic process | 4.05% (3/74) | 2.94 | 0.007251 | 0.018695 |
| GO:0030042 | actin filament depolymerization | 1.35% (1/74) | 6.97 | 0.007973 | 0.018705 |
| GO:0008608 | attachment of spindle microtubules to kinetochore | 1.35% (1/74) | 6.88 | 0.008462 | 0.019392 |
| GO:0051315 | attachment of mitotic spindle microtubules to kinetochore | 1.35% (1/74) | 6.88 | 0.008462 | 0.019392 |
| GO:0034975 | protein folding in endoplasmic reticulum | 1.35% (1/74) | 6.9 | 0.00834 | 0.019472 |
| GO:0004518 | nuclease activity | 4.05% (3/74) | 2.86 | 0.008455 | 0.019558 |
| GO:0009570 | chloroplast stroma | 2.7% (2/74) | 3.85 | 0.008636 | 0.019608 |
| GO:0009532 | plastid stroma | 2.7% (2/74) | 3.85 | 0.008636 | 0.019608 |
| GO:0009725 | response to hormone | 2.7% (2/74) | 3.87 | 0.008446 | 0.019627 |
| GO:0065007 | biological regulation | 13.51% (10/74) | 1.25 | 0.008994 | 0.02033 |
| GO:0009117 | nucleotide metabolic process | 4.05% (3/74) | 2.8 | 0.009454 | 0.021272 |
| GO:0006753 | nucleoside phosphate metabolic process | 4.05% (3/74) | 2.78 | 0.009718 | 0.021767 |
| GO:0032787 | monocarboxylic acid metabolic process | 4.05% (3/74) | 2.77 | 0.009964 | 0.022217 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 4.05% (3/74) | 2.76 | 0.010031 | 0.022267 |
| GO:0033588 | elongator holoenzyme complex | 1.35% (1/74) | 6.61 | 0.01017 | 0.022474 |
| GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.35% (1/74) | 6.58 | 0.010414 | 0.022911 |
| GO:0009719 | response to endogenous stimulus | 2.7% (2/74) | 3.7 | 0.010511 | 0.02292 |
| GO:0031324 | negative regulation of cellular metabolic process | 4.05% (3/74) | 2.74 | 0.010473 | 0.02294 |
| GO:0009892 | negative regulation of metabolic process | 4.05% (3/74) | 2.73 | 0.010629 | 0.023075 |
| GO:0004332 | fructose-bisphosphate aldolase activity | 1.35% (1/74) | 6.53 | 0.010779 | 0.023199 |
| GO:1901576 | organic substance biosynthetic process | 9.46% (7/74) | 1.53 | 0.010751 | 0.023239 |
| GO:0071043 | CUT metabolic process | 1.35% (1/74) | 6.51 | 0.010901 | 0.023259 |
| GO:0071034 | CUT catabolic process | 1.35% (1/74) | 6.51 | 0.010901 | 0.023259 |
| GO:0051668 | localization within membrane | 2.7% (2/74) | 3.65 | 0.011244 | 0.023888 |
| GO:0031080 | nuclear pore outer ring | 1.35% (1/74) | 6.4 | 0.011754 | 0.024864 |
| GO:0050136 | NADH dehydrogenase (quinone) activity | 1.35% (1/74) | 6.37 | 0.011997 | 0.025163 |
| GO:0008137 | NADH dehydrogenase (ubiquinone) activity | 1.35% (1/74) | 6.37 | 0.011997 | 0.025163 |
| GO:0043170 | macromolecule metabolic process | 20.27% (15/74) | 0.9 | 0.012713 | 0.026552 |
| GO:0089701 | U2AF complex | 1.35% (1/74) | 6.25 | 0.013092 | 0.027229 |
| GO:0008334 | histone mRNA metabolic process | 1.35% (1/74) | 6.18 | 0.013699 | 0.028373 |
| GO:0015031 | protein transport | 4.05% (3/74) | 2.58 | 0.01402 | 0.028796 |
| GO:0009058 | biosynthetic process | 9.46% (7/74) | 1.45 | 0.013968 | 0.028809 |
| GO:0055086 | nucleobase-containing small molecule metabolic process | 4.05% (3/74) | 2.57 | 0.014379 | 0.029412 |
| GO:0009082 | branched-chain amino acid biosynthetic process | 1.35% (1/74) | 6.08 | 0.014671 | 0.029762 |
| GO:0030628 | pre-mRNA 3'-splice site binding | 1.35% (1/74) | 6.08 | 0.014671 | 0.029762 |
| GO:0071029 | nuclear ncRNA surveillance | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0043633 | polyadenylation-dependent RNA catabolic process | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0106354 | tRNA surveillance | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0016078 | tRNA catabolic process | 1.35% (1/74) | 6.0 | 0.01552 | 0.030486 |
| GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.35% (1/74) | 5.9 | 0.016611 | 0.032371 |
| GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing | 1.35% (1/74) | 5.9 | 0.016611 | 0.032371 |
| GO:0031125 | rRNA 3'-end processing | 1.35% (1/74) | 5.83 | 0.017458 | 0.03389 |
| GO:0030388 | fructose 1,6-bisphosphate metabolic process | 1.35% (1/74) | 5.8 | 0.017821 | 0.034459 |
| GO:0031126 | sno(s)RNA 3'-end processing | 1.35% (1/74) | 5.72 | 0.018789 | 0.036048 |
| GO:0043628 | regulatory ncRNA 3'-end processing | 1.35% (1/74) | 5.72 | 0.018789 | 0.036048 |
| GO:0003955 | NAD(P)H dehydrogenase (quinone) activity | 1.35% (1/74) | 5.71 | 0.01891 | 0.03614 |
| GO:0043144 | sno(s)RNA processing | 1.35% (1/74) | 5.68 | 0.019272 | 0.036691 |
| GO:0016074 | sno(s)RNA metabolic process | 1.35% (1/74) | 5.67 | 0.019514 | 0.036867 |
| GO:0009086 | methionine biosynthetic process | 1.35% (1/74) | 5.67 | 0.019514 | 0.036867 |
| GO:1901565 | organonitrogen compound catabolic process | 4.05% (3/74) | 2.4 | 0.019609 | 0.036907 |
| GO:0015453 | oxidoreduction-driven active transmembrane transporter activity | 1.35% (1/74) | 5.63 | 0.019997 | 0.037352 |
| GO:0005686 | U2 snRNP | 1.35% (1/74) | 5.63 | 0.019997 | 0.037352 |
| GO:0016832 | aldehyde-lyase activity | 1.35% (1/74) | 5.6 | 0.020479 | 0.03811 |
| GO:0008154 | actin polymerization or depolymerization | 1.35% (1/74) | 5.59 | 0.0206 | 0.038191 |
| GO:0006555 | methionine metabolic process | 1.35% (1/74) | 5.55 | 0.021083 | 0.03894 |
| GO:0071027 | nuclear RNA surveillance | 1.35% (1/74) | 5.53 | 0.021444 | 0.039461 |
| GO:0002098 | tRNA wobble uridine modification | 1.35% (1/74) | 5.37 | 0.023852 | 0.041573 |
| GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.35% (1/74) | 5.37 | 0.023852 | 0.041573 |
| GO:0033047 | regulation of mitotic sister chromatid segregation | 1.35% (1/74) | 5.37 | 0.023973 | 0.041636 |
| GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:0051985 | negative regulation of chromosome segregation | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:1905819 | negative regulation of chromosome separation | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:0033046 | negative regulation of sister chromatid segregation | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:0045839 | negative regulation of mitotic nuclear division | 1.35% (1/74) | 5.38 | 0.023732 | 0.041657 |
| GO:0071025 | RNA surveillance | 1.35% (1/74) | 5.44 | 0.022769 | 0.041744 |
| GO:0071174 | mitotic spindle checkpoint signaling | 1.35% (1/74) | 5.39 | 0.023491 | 0.042439 |
| GO:0071173 | spindle assembly checkpoint signaling | 1.35% (1/74) | 5.39 | 0.023491 | 0.042439 |
| GO:0007094 | mitotic spindle assembly checkpoint signaling | 1.35% (1/74) | 5.39 | 0.023491 | 0.042439 |
| GO:0031577 | spindle checkpoint signaling | 1.35% (1/74) | 5.39 | 0.023491 | 0.042439 |
| GO:0000776 | kinetochore | 1.35% (1/74) | 5.31 | 0.024934 | 0.043155 |
| GO:0051784 | negative regulation of nuclear division | 1.35% (1/74) | 5.28 | 0.025414 | 0.043833 |
| GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.35% (1/74) | 5.25 | 0.025894 | 0.044199 |
| GO:0000176 | nuclear exosome (RNase complex) | 1.35% (1/74) | 5.25 | 0.025894 | 0.044199 |
| GO:0046872 | metal ion binding | 8.11% (6/74) | 1.41 | 0.025767 | 0.044288 |
| GO:0016075 | rRNA catabolic process | 1.35% (1/74) | 5.23 | 0.026374 | 0.04471 |
| GO:0034661 | ncRNA catabolic process | 1.35% (1/74) | 5.23 | 0.026374 | 0.04471 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 5.41% (4/74) | 1.83 | 0.026536 | 0.04483 |
| GO:0003954 | NADH dehydrogenase activity | 1.35% (1/74) | 5.21 | 0.026734 | 0.045011 |
| GO:0002097 | tRNA wobble base modification | 1.35% (1/74) | 5.2 | 0.026854 | 0.04506 |
| GO:0048024 | regulation of mRNA splicing, via spliceosome | 1.35% (1/74) | 5.19 | 0.026974 | 0.045108 |
| GO:0005635 | nuclear envelope | 1.35% (1/74) | 5.19 | 0.027094 | 0.045156 |
| GO:0036002 | pre-mRNA binding | 1.35% (1/74) | 5.18 | 0.027214 | 0.045204 |
| GO:1901135 | carbohydrate derivative metabolic process | 4.05% (3/74) | 2.21 | 0.027457 | 0.045455 |
| GO:0043169 | cation binding | 8.11% (6/74) | 1.37 | 0.028831 | 0.047572 |
| GO:2001251 | negative regulation of chromosome organization | 1.35% (1/74) | 5.06 | 0.029488 | 0.048493 |
